MENU
ALPMY
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Astellas Pharma (ALPMY) Ownership - Who owns Astellas Pharma?
Astellas Pharma Inc is a specialty global pharmaceutical company... Show more
Profile
Industry
N/A
Address
2-5-1, Nihonbashi-Honcho
Phone
+81 332443000
Employees
16243
Web
http://www.astellas.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
26.55B
P/E Ratio
37.59
Total Cash
396.62B
Projected Growth
N/A
Total Debt
30B
Revenue
1.52T
Risk (Beta)
0.30
Dividend Yield
0.03
Total Cash/Share
220.74
Total Debt/Equity
N/A
Revenue/Share
5.91 USD as % of share price
Fundamentals
ALPMY
Capitalization
26.6B
P/E Ratio
37.59
Risk (Beta)
0.30
Dividend Yield
0.03
Total Cash
397B
Total Cash/Share
220.74
Total Debt
30B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.91%
Revenue
1.52T
ROE
N/A
Book Value
1.51T
P/B Ratio
2.43
Cash Flow
N/A
Earnings
54.24
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
103B
Current Ratio
1.45
Current Revenue Per Employee
24458298.00
Dividends Per Share - Security
28.81
EBITDA
247B
Float
N/A
Float - Current
N/A
Gross Income Margin
82.42
Revenue To Assets
4.12
Shares Held By Institutions
17.1M
Shares Outstanding - Current
1.8B
Total Liabilities
949B
Total Volume MTD
N/A
Value
1
Gain YTD
12.319
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ALPMY showed earnings on July 30, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsMajor
Profile
Fundamentals
Details
Industry
N/A
Address
2-5-1, Nihonbashi-Honcho
Phone
+81 332443000
Employees
16243
Web
http://www.astellas.com